Clinical Trial Update: NeoVax Plus Ipilimumab in Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial update testing NeoVax, a personalized neoantigen vaccine, in combination with ipilimumab for renal cell carcinoma; the study is active but not cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• NeoVax
• ipilimumab (ipilimumab)

Snippet

Sponsor: Patrick Ott, MD, PhD | Conditions: Kidney Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING